Literature DB >> 21576249

Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination.

Xiaoyang Luo1, Marguerite Prior, Wanxia He, Xiangyou Hu, Xiaoying Tang, Weizhen Shen, Satya Yadav, Sumiko Kiryu-Seo, Robert Miller, Bruce D Trapp, Riqiang Yan.   

Abstract

Neuregulin-1 (Nrg1) is encoded by a single gene and exists in naturally secreted and transmembrane isoforms. Nrg1 exerts its signaling activity through interaction with its cognate ErbB receptors. Multiple membrane-anchored Nrg1 isoforms, present in six different membrane topologies, must be processed by a protease to initiate a signaling cascade. Here, we demonstrate that BACE1 and ADAM10 can process type I and III Nrg1 at two adjacent sites. Our cleavage site mapping experiments showed that the BACE1 cleavage site is located eight amino acids downstream of the ADAM10 cleavage site, and this order of cleavage is the opposite of amyloid precursor protein cleavage by these two enzymes. Cleavages were further confirmed via optimized electrophoresis. Cleavage of type I or III Nrg1 by ADAM10 and BACE1 released a signaling-capable N-terminal fragment (ntf), either Nrg1-ntfα or Nrg1-ntfβ, which could similarly activate an ErbB receptor as evidenced by increased phosphorylation of Akt and ERK, two downstream signaling molecules. Although both Nrg1-ntfα and Nrg1-ntfβ could initiate a common signaling cascade, inhibition or down-regulation of ADAM10 alone in a co-culture system did not affect normal myelination, whereas specific inhibition of BACE1 impaired normal myelination. Thus, processing of Nrg1 by BACE1 appears to be more critical for regulating myelination. Our results imply that a significant inhibition of BACE1 could potentially impair Nrg1 signaling activity in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576249      PMCID: PMC3129178          DOI: 10.1074/jbc.M111.251538

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1).

Authors:  Shawn J Stachel; Craig A Coburn; Thomas G Steele; Kristen G Jones; Elizabeth F Loutzenhiser; Alison R Gregro; Hemaka A Rajapakse; Ming-Tain Lai; Ming-Chih Crouthamel; Min Xu; Katherine Tugusheva; Janet E Lineberger; Beth L Pietrak; Amy S Espeseth; Xiao-Ping Shi; Elizabeth Chen-Dodson; M Katharine Holloway; Sanjeev Munshi; Adam J Simon; Lawrence Kuo; Joseph P Vacca
Journal:  J Med Chem       Date:  2004-12-16       Impact factor: 7.446

2.  NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination.

Authors:  Xinhua Lee; Zhongshu Yang; Zhaohui Shao; Sheila S Rosenberg; Melissa Levesque; R Blake Pepinsky; Mengsheng Qiu; Robert H Miller; Jonah R Chan; Sha Mi
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

3.  The effects of alpha-secretase ADAM10 on the proteolysis of neuregulin-1.

Authors:  Christian Freese; Alistair N Garratt; Falk Fahrenholz; Kristina Endres
Journal:  FEBS J       Date:  2009-02-11       Impact factor: 5.542

4.  Biochemical and cell-based assays for characterization of BACE-1 inhibitors.

Authors:  Beth L Pietrak; Ming-Chih Crouthamel; Katherine Tugusheva; Janet E Lineberger; Min Xu; Jillian M DiMuzio; Thomas Steele; Amy S Espeseth; Shawn J Stachel; Craig A Coburn; Samuel L Graham; Joseph P Vacca; Xiao-Ping Shi; Adam J Simon; Daria J Hazuda; Ming-Tain Lai
Journal:  Anal Biochem       Date:  2005-07-01       Impact factor: 3.365

5.  In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.

Authors:  Sethu Sankaranarayanan; Eric A Price; Guoxin Wu; Ming-Chih Crouthamel; Xiao-Ping Shi; Katherine Tugusheva; Keala X Tyler; Jason Kahana; Joan Ellis; Lixia Jin; Thomas Steele; Shawn Stachel; Craig Coburn; Adam J Simon
Journal:  J Pharmacol Exp Ther       Date:  2007-12-21       Impact factor: 4.030

6.  Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves.

Authors:  Xiangyou Hu; Wanxia He; Claudiu Diaconu; Xiaoying Tang; Grahame J Kidd; Wendy B Macklin; Bruce D Trapp; Riqiang Yan
Journal:  FASEB J       Date:  2008-04-15       Impact factor: 5.191

7.  The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein.

Authors:  Tobias M J Allinson; Edward T Parkin; Thomas P Condon; Sylva L U Schwager; Edward D Sturrock; Anthony J Turner; Nigel M Hooper
Journal:  Eur J Biochem       Date:  2004-06

8.  Rational design and synthesis of selective BACE-1 inhibitors.

Authors:  Stephen F Brady; Satendra Singh; Ming Chih Crouthamel; M Katharine Holloway; Craig A Coburn; Victor M Garsky; Michael Bogusky; Michael W Pennington; Joseph P Vacca; Daria Hazuda; Ming-Tain Lai
Journal:  Bioorg Med Chem Lett       Date:  2004-02-09       Impact factor: 2.823

9.  Association of Wwox with ErbB4 in breast cancer.

Authors:  Rami I Aqeilan; Valentina Donati; Eugenio Gaudio; Milena S Nicoloso; Maria Sundvall; Anna Korhonen; Johan Lundin; Jorma Isola; Marius Sudol; Heikki Joensuu; Carlo M Croce; Klaus Elenius
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

Review 10.  Axon-glial signaling and the glial support of axon function.

Authors:  Klaus-Armin Nave; Bruce D Trapp
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

View more
  61 in total

1.  BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice.

Authors:  Xiao-Xin Yan; Yan Cai; Xue-Mei Zhang; Xue-Gang Luo; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  Exp Neurol       Date:  2012-01-11       Impact factor: 5.330

2.  Nicastrin functions to sterically hinder γ-secretase-substrate interactions driven by substrate transmembrane domain.

Authors:  David M Bolduc; Daniel R Montagna; Yongli Gu; Dennis J Selkoe; Michael S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

3.  BACE1 regulates hippocampal astrogenesis via the Jagged1-Notch pathway.

Authors:  Xiangyou Hu; Wanxia He; Xiaoyang Luo; Katherine Elyse Tsubota; Riqiang Yan
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

4.  BACE1 regulates the proliferation and cellular functions of Schwann cells.

Authors:  Xiangyou Hu; Hailong Hou; Chinthasagar Bastian; Wanxia He; Shupeng Qiu; Yingying Ge; Xinhua Yin; Grahame J Kidd; Sylvain Brunet; Bruce D Trapp; Selva Baltan; Riqiang Yan
Journal:  Glia       Date:  2017-02-13       Impact factor: 7.452

Review 5.  Schwann cell myelination.

Authors:  James L Salzer
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-06-08       Impact factor: 10.005

6.  Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice.

Authors:  Xiaoyang Luo; Wanxia He; Xiangyou Hu; Riqiang Yan
Journal:  Biol Psychiatry       Date:  2013-10-05       Impact factor: 13.382

Review 7.  Targeting the β secretase BACE1 for Alzheimer's disease therapy.

Authors:  Riqiang Yan; Robert Vassar
Journal:  Lancet Neurol       Date:  2014-02-17       Impact factor: 44.182

8.  Rapid transient isoform-specific neuregulin1 transcription in motor neurons is regulated by neurotrophic factors and axon-target interactions.

Authors:  Jiajing Wang; Abdelkrim Hmadcha; Vaagn Zakarian; Fei Song; Jeffrey A Loeb
Journal:  Mol Cell Neurosci       Date:  2015-04-22       Impact factor: 4.314

Review 9.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

10.  Proteolytic Processing of Neuregulin 1 Type III by Three Intramembrane-cleaving Proteases.

Authors:  Daniel Fleck; Matthias Voss; Ben Brankatschk; Camilla Giudici; Heike Hampel; Benjamin Schwenk; Dieter Edbauer; Akio Fukumori; Harald Steiner; Elisabeth Kremmer; Martina Haug-Kröper; Moritz J Rossner; Regina Fluhrer; Michael Willem; Christian Haass
Journal:  J Biol Chem       Date:  2015-11-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.